3-D MatrixDMTRF +11.11%57 Receivables Turnover is 1.14 as of Jan. 2026. GuruFocus rates DMTRF with a GF Score™ of 57/100 and a GF Value™ of $2.16 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 812 Medical Devices & Instruments companies, 3-D Matrix ranks worse than 60.84% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. 3-D Matrix's Revenue for the
three
months ended in Jan. 2026 was $16.21 Mil. 3-D Matrix's average Accounts Receivable for the
three
months ended in Jan. 2026 was $14.25 Mil.
Hence, 3-D Matrix's Receivables Turnover for the
three
months ended in Jan. 2026 was 1.14.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
3-D Matrix Receivables Turnover Related Terms
3-D Matrix Receivables Turnover Historical Data
* Premium members only.
The historical data trend for 3-D Matrix's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DMTRF vs ABT, SYK, MDT: Receivables Turnover Comparison
For the Medical Devices subindustry, 3-D Matrix's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
3-D Matrix Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 3-D Matrix's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where 3-D Matrix's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
3-D Matrix (DMTRF) has a Receivables Turnover of 1.14 as of Jan. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on 3-D Matrix and its competitors. According to the industry distribution chart, 3-D Matrix ranks #494 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 60.8%.
Is 3-D Matrix's Receivables Turnover too high?
3-D Matrix's current Receivables Turnover is 1.14. The Medical Devices & Instruments industry median Receivables Turnover is 5.53. 3-D Matrix's value of 1.14 is 79.4% below this industry median. Based on the distribution chart, 3-D Matrix ranks #494 out of 812 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, 3-D Matrix has a GF Score™ of 57/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 3-D Matrix's Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, 3-D Matrix ranks #494 out of 812 companies for Receivables Turnover. This places 3-D Matrix in the lower half of its industry. The industry median Receivables Turnover is 5.53. 3-D Matrix's value of 1.14 is 79.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.53, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 3-D Matrix's current Receivables Turnover of 1.14 is 79.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on 3-D Matrix and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 3-D Matrix's current Receivables Turnover is 1.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 3-D Matrix stock overvalued right now?
Based on GuruFocus' analysis, 3-D Matrix (DMTRF) is currently considered Modestly Overvalued. The stock's GF Value™ is $2.16, compared to a current price of $2.50 — trading 15.7% above its estimated fair value. The current Receivables Turnover is 1.14 and 79.4% below the Medical Devices & Instruments industry median of 5.53. 3-D Matrix's overall GF Score™ is 57/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For 3-D Matrix (DMTRF), the current Receivables Turnover is 1.14 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 3-D Matrix (DMTRF) Overvalued in 2026?
Based on GuruFocus' analysis, 3-D Matrix stock appears to be overvalued.
The current stock price of $2.50 is trading 15.7% above its estimated GF Value™ of $2.16.
GuruFocus considers 3-D Matrix to be Modestly Overvalued.
Key valuation signals for DMTRF:
Receivables Turnover: 1.14
GF Value™: $2.16 vs. price of $2.50 (15.7% above fair value)
Industry Position: 79.4% below the Medical Devices & Instruments median (#494 of 812)
No single metric tells the full story. See the DMTRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
3-D Matrix Ltd is engaged in the research, development, manufacture, and sale of medical devices based on the self-assembling peptide technology. Its products include PuraMatrix, High Concentration PuraMatrix, Modified Peptide and GMP Grade PuraMatrix.
57GF Score
Get the complete analysis for DMTRF
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DMTRF has been successfully added to your 
